Statement Of Cash Flows [Abstract]
| Concept |
2021-09-19 to 2022-09-17 |
2020-09-13 to 2021-09-18 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income |
19,000,000
GBP
|
9,000,000
GBP
|
| Adjustments for decrease (increase) in trade and other receivables |
288,000,000
GBP
|
98,000,000
GBP
|
| Adjustments for increase (decrease) in trade and other payables |
512,000,000
GBP
|
175,000,000
GBP
|
| Adjustments for decrease (increase) in biological assets |
4,000,000
GBP
|
1,000,000
GBP
|
| Adjustments for amortisation expense |
68,000,000
GBP
|
74,000,000
GBP
|
| Adjustments for depreciation expense |
802,000,000
GBP
|
823,000,000
GBP
|
| Adjustments for undistributed profits of investments accounted for using equity method |
109,000,000
GBP
|
79,000,000
GBP
|
| Cash flows from (used in) investing activities [abstract] | ||
| Dividends received from investments accounted for using equity method, classified as investing activities |
93,000,000
GBP
|
63,000,000
GBP
|
| Cash flows from (used in) financing activities [abstract] | ||
| Dividends paid to equity holders of parent, classified as financing activities |
380,000,000
GBP
|
49,000,000
GBP
|
| Dividends paid to non-controlling interests, classified as financing activities |
8,000,000
GBP
|
4,000,000
GBP
|